On May 9, 2024, Bristol-Myers Squibb Company announced that it held its annual general meeting of shareholders on May 7, 2024, and declared voting results. Accordingly, a shareholder proposal from John Chevedden, on executive retention of significant stock was not approved.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.7 USD | -0.16% | +3.76% | -18.12% |
03:31pm | Bristol-Myers Squibb Says Opdivo Plus Yervoy Therapy Improves Survival of Liver Cancer Patients | MT |
02:38pm | Bristol Myers: positive results in liver cancer | CF |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.12% | 84.67B | |
+42.27% | 748B | |
+33.99% | 598B | |
-5.93% | 356B | |
+18.38% | 325B | |
+4.78% | 283B | |
+17.40% | 245B | |
+9.05% | 211B | |
-4.34% | 209B | |
+2.69% | 166B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Declaration of Voting Results by Bristol-Myers Squibb Company